NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
He Ren
Tianjin Medical University - Tianjin / China
Others
AD Scientific Index ID: 4988582
天津医科大学
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
He Ren's MOST POPULAR ARTICLES
1-)
Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism K Chen, D Wang, WT Du, ZB Han, H Ren, Y Chi, SG Yang, D Zhu, ... Clinical immunology 135 (3), 448-458, 2010 2502010
2-)
Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancerX Zhao, F Li, Y Li, H Wang, H Ren, J Chen, G Nie, J HaoBiomaterials 46, 13-25, 20152462015
3-)
Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpuraT Wang, H Zhao, H Ren, J Guo, M Xu, R Yang, ZC HanHaematologica 90 (7), 914-923, 20052392005
4-)
Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapyX Zhao, K Yang, R Zhao, T Ji, X Wang, X Yang, Y Zhang, K Cheng, S Liu, ...Biomaterials 102, 187-197, 20162382016
5-)
Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+ Treg cells in pancreatic ductal adenocarcinomaX Wang, M Lang, T Zhao, X Feng, C Zheng, C Huang, J Hao, J Dong, ...Oncogene 36 (21), 3048-3058, 20172212017
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept